Inventor · disambiguated record
Steven M. Chamow
Also filed as: CHAMOW STEVEN · CHAMOW STEVEN M
17 granted patents·6 pending applications·472 citations·filing 1992–2023
95Inventor score
Files withGENENTECH INC9FORSIGHT VISION4 INC6FARINAS KATHLEEN COGAN3DE JUAN JR EUGENE2FORSIGHT LABS LLC1
Top patents by PatentIndex Score
23 records- 0198US8399006B2Posterior segment drug deliveryDE JUAN JR EUGENE·Filed 2010·Granted Mar 19, 2013·103 cites·27 claims
- 0297US8808727B2Posterior segment drug deliveryFORSIGHT VISION4 INC·Filed 2013·Granted Aug 19, 2014·45 cites·7 claims
- 0396US11065151B2Therapeutic agent formulations for implanted devicesFORSIGHT VISION4 INC·Filed 2020·Granted Jul 20, 2021·3 cites·14 claims
- 0495US11642310B2Posterior segment drug deliveryFORSIGHT VISION4 INC·Filed 2020·Granted May 9, 2023·3 cites·26 claims
- 0594US5329028ACarbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 1992·Granted Jul 12, 1994·87 cites·13 claims
- 0691US10656152B2Posterior segment drug deliveryFORSIGHT VISION4 INC·Filed 2017·Granted May 19, 2020·5 cites·29 claims
- 0791US6582928B1Carbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 2000·Granted Jun 24, 2003·16 cites·17 claims
- 0890US5889155ACarbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 1995·Granted Mar 30, 1999·83 cites·18 claims
- 0988US10874548B2Therapeutic agent formulations for implanted devicesFORSIGHT VISION4 INC·Filed 2017·Granted Dec 29, 2020·2 cites·16 claims
- 1087US2023338282A1Posterior segment drug deliveryFORSIGHT VISION4 INC·Filed 2023·Application pending·0 cites
- 1185US5464815AInhibition of heparin-bindingGENENTECH INC·Filed 1994·Granted Nov 7, 1995·67 cites·27 claims
- 1273US6124435ACarbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 1998·Granted Sep 26, 2000·10 cites·22 claims
- 1366US5849689AMethod of extending the plasma half-life of deletion variants of hepatocyte growth factorGENENTECH INC·Filed 1995·Granted Dec 15, 1998·22 cites·23 claims
- 1461US2014031769A1Therapeutic agent formulations for implanted devicesDE JUAN JR EUGENE·Filed 2011·Application pending·0 cites
- 1560US2011282093A1Heterobifunctional polyethylene glycol reagentsLEVY DANIEL E·Filed 2008·Application pending·0 cites
- 1659US5605791ACarbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 1995·Granted Feb 25, 1997·6 cites·9 claims
- 1755US2014248296A1Sustained drug delivery systemFARINAS KATHLEEN COGAN·Filed 2013·Application pending·0 cites
- 1854US5929211ACarbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 1997·Granted Jul 27, 1999·11 cites·17 claims
- 1954US2004191243A1System and method for stabilizing antibodies with histidineFiled 2003·Application pending·0 cites
- 2050US8535681B2Sustained drug delivery systemFARINAS KATHLEEN COGAN·Filed 2009·Granted Sep 17, 2013·0 cites·14 claims
- 2149US5851989AMethod of extending the plasma half-life of vascular endothelial cell growth factorGENENTECH INC·Filed 1995·Granted Dec 22, 1998·9 cites·14 claims
- 2249US2016287719A1Sustained drug delivery systemFORSIGHT LABS LLC·Filed 2016·Application pending·0 cites
- 2343US8530189B2Sustained drug delivery systemFARINAS KATHLEEN COGAN·Filed 2011·Granted Sep 10, 2013·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →